Development of inhaled vancomycin for treatment of mrsa infections in CF

Ended Project Grant Awarded Last action

Award ID
R43HL112393
Recipient
Awarding agency
Obligated
$149,750

Award facts

Assistance listing
93.838 Lung Diseases Research
Completion date
Place of performance
Austin, TX 78730, USA

Award details come from USAspending.gov.

Quick answers

Who received award R43HL112393?

R43HL112393 was awarded to Aravas Inc. by National Institutes of Health (Department of Health and Human Services) on May 1, 2012.

How much is award R43HL112393 worth?

$149,750 has been obligated on R43HL112393.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award